Context.-Many studies have found a significant inverse association between early exposure to environmental lead and cognitive function in childhood. Whether these effects are reversible when exposure is reduced is not clear. Objective.-To assess the reversibility of the apparent effects of lead on cognitive abilities in early childhood by testing whether declines in blood lead concentrations beyond the age of 2 years are associated with improvements in cognition. Setting.-Urban and rural communities surrounding a large lead smelter in Port Pirie, South Australia. Participants.-A total of 375 children followed up from birth to the age of 11 to 13 years. Design.-Long-term prospective cohort study. Main Outcome Measures.-The Bayley Mental Development Index at age 2 years, the McCarthy General Cognitive Index at age 4 years, and IQs from the Wechsler Intelligence Scale (revised version) at ages 7 and 11 to 13 years. Results.-Mean blood lead concentrations in the children decreased from 1.02 µmol/L (21.2 µg/dL) at age 2 years to 0.38 µmol/L (7.9 µg/dL) at age 11 to 13 years, but cognitive scores in children whose blood lead concentration declined most were generally not improved relative to the scores of children whose blood lead levels declined least. Changes in IQ and declines in blood lead levels that occurred between the ages of 7 and 11 to 13 years (r = 0.12, P = .09) suggested slightly better cognition among children whose blood lead levels declined most. Conclusion.-The cognitive deficits associated with exposure to environmental lead in early childhood appear to be only partially reversed by a subsequent decline in blood lead level.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.